skip to Main Content

Allogeneic Hematopoietic Stem cell Transplantation (HSCT) improves probability of survival in patients with high risk myelodysplastic syndromes: a prospective randomized comparison of allogeneic HSCT, autologous SCT or chemotherapy.

Back To Top